[Treatment guidelines for hyperglycaemia in type 2 diabetes patients with stable chronic heart failure or ischemic cardiomyopathy without heart failure].
Alonso-García
Angeles
A
Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Madrid, España. angelesalonsog@secardiologia.es
García-Soidán
Francisco J
FJ
Lisbona-Gil
Arturo
A
D054058:Acute Coronary Syndrome / Q000097:blood / Q000150:complications; D000465:Algorithms; D032921:Consensus; D000075202:Contraindications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005544:Forecasting; D006442:Glycated Hemoglobin / Q000032:analysis; D006333:Heart Failure / Q000097:blood* / Q000150:complications; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy* / Q000209:etiology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008687:Metformin / Q000008:administration & dosage / Q000627:therapeutic use; D017202:Myocardial Ischemia / Q000097:blood* / Q000150:complications; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D013030:Spain; D045162:Thiazolidinediones / Q000008:administration & dosage / Q000627:therapeutic use
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin; D045162:Thiazolidinediones
Tratamiento hipoglucemiante en pacientes con diabetes mellitus tipo 2 con insuficiencia cardiaca estable o cardiopatía isquémica sin insuficiencia cardiaca.